| Place of Origin: | China |
|---|---|
| Brand Name: | HNB |
| Certification: | ISO |
| Model Number: | HNB-Lamivudine |
| Minimum Order Quantity: | 1KG |
| Price: | Negotiable |
| Packaging Details: | Aluminum foil bag |
| Delivery Time: | Usually7-10days |
| Payment Terms: | L/C, D/A, D/P, T/T, , MoneyGram |
| Supply Ability: | 5000kg/Month |
| CAS: | 134678-17-4 | Mf: | C8H11N3O3S |
|---|---|---|---|
| MW: | 229.256 | Specification: | ≥98% |
| Appearance: | White Powder | Purity: | 99%,99%min |
| Shelf Life: | 2 Years | Grade: | Medical Grade,Phamaceutical Grade,Medicine & Tech,USP BP FCC EP |
| High Light: | Pharmaceutical Grade Lamivudine Powder Powder,CAS 134678-17-4 API Pharmaceutical,Antiviral Agent Lamivudine Powder Powder |
||
CAS 134678-17-4 Lamivudine powder API antiviral agent powder
The Introductction
Lamivudine is a nucleoside reverse transcriptase inhibitor (NRTIs). Lamivudine inhibits HIV reverse transcriptase 1 and 2 and the reverse transcriptase of hepatitis B virus.
Lamivudine, an organic compound with the chemical formula C8H11N3O3S, is primarily used as an antiviral and has a competitive inhibitory effect on the synthesis and lengthening of viral DNA strands.
| Product Name: | Lamivudine |
| Synonyms: |
(-)-1-[(2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine |
| CAS: | 134678-17-4 |
| MF: | C8H11N3O3S |
| MW: | 229.256 |
The Application & Function
Lamivudine use for Hepatitis B, hepatitis B virus replication of chronic hepatitis B.
The COA
| Item | Specification | Results |
| APPEARANCE | WHITE | CONFORMS |
| SOLUBILITY | FREELY SOLUBLE IN CHLOROFORM;SOLUBLE IN WATER OR METHANOL; | CONFORMS |
| PH | 5.0-7.2 | 6.51 |
| LOSS ON DRYING | ≤4.5% | 3.10% |
| RESIDUEON IGNITION | ≤2.5% | 0.281% |
| HEAVY METALS | ≤20PPM | <15PPM |
| TYRAMINE | ≤0.35% | 0.051% |
| RELATED COMPOSITIONS | TYLOSIN A ≥80% A+B+C+D ≥95% | 93% 98% |
| Conclusion | Confirm with the standard |